🇺🇸 FDA
Pipeline program

Intraarterial infusion of autologous bone marrow cells

CMMo/ICPD/2008

Phase 2 other completed

Quick answer

Intraarterial infusion of autologous bone marrow cells for Critical Limb Ischemia (CLI) is a Phase 2 program (other) at Lxo Ireland Designated Activity Company with 2 ClinicalTrials.gov record(s).

Program details

Company
Lxo Ireland Designated Activity Company
Indication
Critical Limb Ischemia (CLI)
Phase
Phase 2
Modality
other
Status
completed

Clinical trials